• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CURONIX LLC FREEDOM PERIPHERAL NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CURONIX LLC FREEDOM PERIPHERAL NERVE STIMULATOR Back to Search Results
Model Number STQ4-SPR-B0
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pain (1994)
Event Date 09/20/2023
Event Type  Injury  
Event Description
The patient reported pain at the incision site.The patient has not used therapy since the permanent device was implanted.An explant procedure was performed on (b)(6), 2023.The patient is doing fine and no further issues have been reported.
 
Manufacturer Narrative
The unintended stimulation/new pain questionnaire was reviewed for potential causes of the reported issue.Based on this review, the waa providing therapy when the new pain occurred, the patient experiencing heat sensation/shock, and changing the waa parameters intentionally or unintentionally, and the patient experiencing new pain in a new area that is not targeted for therapy have been ruled out as potential causes.However, migration was confirmed.The physician stated the pain had nothing to do with the implant, the site was not infected and antibiotics were not prescribed.The stimulator is used to treat pain.The cause of the reported issue is due to migration.However, the cause of the migration is unknown.Therefore, conclusion has been selected as no problem/fault found.Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in unintended stimulation/new pain issues.Unintended stimulation/new pain issue rates remain acceptably low; thus, capa is not required. unintended stimulation/new pain issue rates will continue to be tracked and trended.
 
Manufacturer Narrative
The unintended stimulation/new pain questionnaire was reviewed for potential causes of the reported issue.Based on this review, the waa providing therapy when the new pain occurred, the patient experiencing heat sensation/shock, and changing the waa parameters intentionally or unintentionally, and the patient experiencing new pain in a new area that is not targeted for therapy have been ruled out as potential causes.However, migration was confirmed.The physician stated the pain had nothing to do with the implant, the site was not infected and antibiotics were not prescribed.The stimulator is used to treat pain.The cause of the reported issue is unknown.The investigation findings do not lead to a clear conclusion about the cause of the reported issue.Therefore, conclusion has been selected as unable to determine root cause.Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in unintended stimulation/new pain issues.Unintended stimulation/new pain issue rates remain acceptably low; thus, capa is not required. unintended stimulation/new pain issue rates will continue to be tracked and trended.Updated per fda capa-2023-0013 correction 2.
 
Event Description
The patient reported pain at the incision site.The patient has not used therapy since the permanent device was implanted.An explant procedure was performed on (b)(6) 2023.The patient is doing fine and no further issues have been reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREEDOM PERIPHERAL NERVE STIMULATOR
Type of Device
PERIPHERAL NERVE STIMULATOR
Manufacturer (Section D)
CURONIX LLC
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer (Section G)
CURONIX LLC
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer Contact
alicia pagliaro
1310 park central boulevard s.
pompano beach, FL 33064
8009655134
MDR Report Key17977064
MDR Text Key326171176
Report Number3010676138-2023-00219
Device Sequence Number1
Product Code GZF
UDI-Device Identifier00818225020495
UDI-Public(01)00818225020495(17)221201
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K171366
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 04/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/20/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date12/01/2022
Device Model NumberSTQ4-SPR-B0
Device Lot NumberSWO201220
Was Device Available for Evaluation? No
Date Manufacturer Received09/20/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/24/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-